The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 04, 2015

Filed:

Oct. 20, 2011
Applicants:

Yoshihiro Ishikawa, Yokohama, JP;

Satoshi Okumura, Yokohama, JP;

Yujiro Hoshino, Yokohama, JP;

Seiichi Inoue, Yokohama, JP;

Inventors:

Yoshihiro Ishikawa, Yokohama, JP;

Satoshi Okumura, Yokohama, JP;

Yujiro Hoshino, Yokohama, JP;

Seiichi Inoue, Yokohama, JP;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A01N 43/04 (2006.01); A61K 31/70 (2006.01); C07H 19/06 (2006.01); A61K 31/7064 (2006.01); A61K 31/7056 (2006.01); A61K 31/706 (2006.01); A61K 31/7052 (2006.01); A61K 31/7042 (2006.01); A61K 31/7076 (2006.01); C07H 19/19 (2006.01); A23L 1/30 (2006.01);
U.S. Cl.
CPC ...
C07H 19/06 (2013.01); A23L 1/30 (2013.01); A61K 31/706 (2013.01); A61K 31/7042 (2013.01); A61K 31/7052 (2013.01); A61K 31/7056 (2013.01); A61K 31/7064 (2013.01); A61K 31/7076 (2013.01); C07H 19/19 (2013.01);
Abstract

The present invention provides a novel compound capable of inhibiting cardiac adenylyl cyclase. The present invention relates to a compound represented by the following formula (I) or a pharmaceutically acceptable salt, ester or solvate thereof: where R, Rand Reach independently represent a hydrogen atom or an acyl group having an acidic or basic substituent, provided that all of R, Rand Rare not simultaneously a hydrogen atom. The present invention also provides a modulator of adenylyl cyclase activity, a pharmaceutical composition and a food composition, all of which comprise the above-described compound or a pharmaceutically acceptable salt, ester or solvate thereof.


Find Patent Forward Citations

Loading…